Serial Casting vs Combined Intervention with Botulinum Toxin A and Serial Casting in the Treatment of Spastic Equinus in Children

Pediatric Physical Therapy

Volumn 15, Issue 4, 2003, Pages 216-220

  Booth, Melissa Y ^a   Yates, Charlotte C ^a   Edgar, Terence S ^b   Bandy, William D ^c  

^a ARKANSAS CHILDREN S HOSPITAL   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF CENTRAL ARKANSAS   (United States)

Author keywords

Botulinum toxin type Altherapeutic use; Cerebral palsy; Child; Comparative studies; Physical therapy techniques; Retrospective studies; Treatment outcome

Indexed keywords

BOTULINUM TOXIN A;

ANKLE; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INTERMETHOD COMPARISON; JOINT FUNCTION; JOINT MOBILITY; PHYSIOTHERAPY; REVIEW; SERIAL CASTING; SPASTIC EQUINUS; SPASTICITY; TREATMENT OUTCOME;

EID: 0344826513     PISSN: 08985669     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PEP.0000096382.65499.E2     Document Type: Review

References (19)

1. Gage JR. Gait Analysis in Cerebral Palsy. New York: Cambridge University Press, 1991.
2. Rose J, Gamble J. Human Walking. 2nd ed. Baltimore: Williams & Wilkins, 1994.
3. Cusick BD. Splints and casts; managing foot deformity in children with neuromotor disorders. Phys Ther. 1988;68:1903-1912.
4. Donatelli RA. The Biomechanics of the Foot and Ankle. 2nd ed. Philadelphia: FA Davis; 1996.
5. Gossman M, Sahrmann S, Rose S. Review of length associated changes in muscle: experimental evidence and clinical implications. Phys Ther. 1982;62:1799-1808.
6. O'Dwyer NJ, Neilson PD, Nash J. Mechanisms of muscle growth related to muscle contracture in cerebral palsy. Dev Med Child Neurol. 1989;31:543-552.
7. Tardieu G, Tardieu C, Colbeau-Justin P, et al. Muscle hypoextensibility in children with cerebral palsy: II. Therapeutic implications. Arch Phys Med Rehabil. 1982;63:103-107.
8. Koman LA, Mooney JF III, Smith BP, et al. Management of cerebral palsy with botulinum A toxin: preliminary investigation. J Pediatr Orthop. 1993;13:489-495.
9. Cosgrove AP, Corry IS, Graham HK. Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol. 1994;36:386-396.
10. Massin M, Allington N. Role of exercise testing in the functional assessment of cerebral palsy children after botulinum A toxin injection. J Pediatr Orthop. 1999;19:362-365.
11. Eames NWA, Baker R, Hill N, et al. The effect of botulinum toxin A on gastrocnemius length: magnitude and duration of response. Dev Med Child Neurol. 1999;41:226-232.
12. Boyd RN, Pliatsios V, Starr R, et al. Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsy. Dev Med Child Neurol. 2000;42:32-41.
13. Leach J. Children undergoing treatment with botulinum toxin: the role of the physical therapist. Muscle Nerve. 1997;20(Suppl 6): S194-S207.
14. Russman SR, Tilton A, Gormley ME. Cerebral palsy: a rational approach to a treatment protocol, and the role of botulinum toxin in treatment. Muscle Nerve. 1997;20(Suppl 6):S181-S193.
15. Tardieu C, Lespargot A, Tabary C, et al. For how long must the soleus be stretched each day to prevent contracture? Dev Med Child Neurol. 1988;30:3-10.
16. Tardieu G, Tardieu C, Colbeau-Justin P, et al. Muscle hypoextensibility in children with cerebral palsy: I. Clinical and experimental observations. Arch Phys Med Rehabil. 1982;63:97-102.
17. Lee KC, Carson L, Kinnin E, et al. The Ashworth scale. A reliable and reproducible method of measuring spasticity. J Neuro Rehabil. 1989;3:205-209.
18. Boyd RN, Graham HK. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children of cerebral palsy. Eur J Neurol. 1999;6(Suppl 4):S23-S35.
19. Cusick BD. Progressive Casting and Splinting for Lower Extremity Deformity in Children with Neuromotor Dysfunction. Tucson, AZ: Therapy Skill Builders; 1990.